Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Transgene Biotek has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2025. The certificate was issued by their Registrar and Share Transfer Agent, Bigshare Services Private Limited, on 11 October 2025. It confirms that shares received for dematerialization from depository participants (NSDL and CDSL) between 1 July 2025 and 30 September 2025 were properly processed. The RTA also confirmed that cancelled security certificates were mutilated, verified, and the depositories' names were substituted in the register of members within the required 15-day window. This is a routine quarterly compliance filing with no operational or financial details disclosed.
This is a standard regulatory compliance filing with no material impact on the business, financials, or stock price. It simply confirms the smooth functioning of share dematerialization processes during the quarter.